- Home
- BNL vs APLS Comparison
BNL vs APLS Comparison
Compare BNL & APLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNL
- APLS
- Stock Information
- Founded
- BNL 2007
- APLS 2009
- Country
- BNL United States
- APLS United States
- Employees
- BNL N/A
- APLS N/A
- Industry
- BNL Real Estate Investment Trusts
- APLS Biotechnology: Pharmaceutical Preparations
- Sector
- BNL Real Estate
- APLS Health Care
- Exchange
- BNL Nasdaq
- APLS Nasdaq
- Market Cap
- BNL 3.5B
- APLS 3.5B
- IPO Year
- BNL 2020
- APLS 2017
- Fundamental
- Price
- BNL $18.45
- APLS $25.04
- Analyst Decision
- BNL Buy
- APLS Buy
- Analyst Count
- BNL 7
- APLS 20
- Target Price
- BNL $19.71
- APLS $33.47
- AVG Volume (30 Days)
- BNL 1.6M
- APLS 2.2M
- Earning Date
- BNL 10-29-2025
- APLS 11-04-2025
- Dividend Yield
- BNL 6.26%
- APLS N/A
- EPS Growth
- BNL N/A
- APLS N/A
- EPS
- BNL 0.52
- APLS N/A
- Revenue
- BNL $442,203,000.00
- APLS $754,649,000.00
- Revenue This Year
- BNL $4.91
- APLS $22.11
- Revenue Next Year
- BNL $5.98
- APLS N/A
- P/E Ratio
- BNL $35.72
- APLS N/A
- Revenue Growth
- BNL 3.85
- APLS 20.02
- 52 Week Low
- BNL $13.96
- APLS $16.10
- 52 Week High
- BNL $18.86
- APLS $35.72
- Technical
- Relative Strength Index (RSI)
- BNL 56.74
- APLS 57.04
- Support Level
- BNL $17.53
- APLS $21.07
- Resistance Level
- BNL $18.75
- APLS $23.50
- Average True Range (ATR)
- BNL 0.29
- APLS 0.78
- MACD
- BNL -0.01
- APLS 0.18
- Stochastic Oscillator
- BNL 77.46
- APLS 98.72
About BNL Broadstone Net Lease Inc.
Broadstone Net Lease Inc is an internally managed real estate investment trust that invests in, owns, and manages single-tenant commercial real estate properties that are net leased on a long-term basis to a diversified group of tenants. The company has selectively invested in net leased assets in the industrial, healthcare, restaurant, retail, and office property types. The company focuses on investing in real estate that is operated by creditworthy single tenants in industries characterized by positive business drivers and trends. The company targets properties that are an integral part of the tenants' businesses and are therefore opportunities to secure long-term net leases.
About APLS Apellis Pharmaceuticals Inc.
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.